1. Home
  2. IRD vs VTSI Comparison

IRD vs VTSI Comparison

Compare IRD & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • VTSI
  • Stock Information
  • Founded
  • IRD 2018
  • VTSI 1993
  • Country
  • IRD United States
  • VTSI United States
  • Employees
  • IRD N/A
  • VTSI N/A
  • Industry
  • IRD
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • IRD
  • VTSI Consumer Discretionary
  • Exchange
  • IRD NYSE
  • VTSI Nasdaq
  • Market Cap
  • IRD 62.0M
  • VTSI 67.3M
  • IPO Year
  • IRD N/A
  • VTSI N/A
  • Fundamental
  • Price
  • IRD $0.95
  • VTSI $6.07
  • Analyst Decision
  • IRD Strong Buy
  • VTSI Strong Buy
  • Analyst Count
  • IRD 3
  • VTSI 1
  • Target Price
  • IRD $6.33
  • VTSI $7.00
  • AVG Volume (30 Days)
  • IRD 2.4M
  • VTSI 72.8K
  • Earning Date
  • IRD 08-15-2025
  • VTSI 08-11-2025
  • Dividend Yield
  • IRD N/A
  • VTSI N/A
  • EPS Growth
  • IRD N/A
  • VTSI N/A
  • EPS
  • IRD N/A
  • VTSI 0.19
  • Revenue
  • IRD $13,651,000.00
  • VTSI $26,164,645.00
  • Revenue This Year
  • IRD $51.41
  • VTSI $9.92
  • Revenue Next Year
  • IRD $68.84
  • VTSI $16.54
  • P/E Ratio
  • IRD N/A
  • VTSI $31.97
  • Revenue Growth
  • IRD N/A
  • VTSI N/A
  • 52 Week Low
  • IRD $0.65
  • VTSI $3.57
  • 52 Week High
  • IRD $2.18
  • VTSI $9.40
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • VTSI 54.39
  • Support Level
  • IRD N/A
  • VTSI $5.83
  • Resistance Level
  • IRD N/A
  • VTSI $6.41
  • Average True Range (ATR)
  • IRD 0.00
  • VTSI 0.35
  • MACD
  • IRD 0.00
  • VTSI -0.08
  • Stochastic Oscillator
  • IRD 0.00
  • VTSI 36.10

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: